Pharmacological management of sleep apnoea

Bibliography

• YOUNG T, PEPPARD PE, GOTTLIEB DJ: Epidemiology of obstructive sleep apnea: a population health perspective. Am. J. Respir. Crit. Care Med. (2002) 165(9):1217-1239.
   PubMed Web of Science ®Google Scholar
• DURAN J, ESNAOLA S, RUBIO R, IZTUETA A: Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am. J. Respir. Crit. Care Med. (2001) 163(3 Pt 1):685-689.
   PubMed Web of Science ®Google Scholar
• BIXLER EO, VGONTZAS AN, TEN HAVE T, TYSON K, KALES A: Effects of age on sleep apnea in men: I. Prevalence and severity. Am. J. Respir. Crit. Care Med. (1998) 157(1):144-148.
   PubMed Web of Science ®Google Scholar
• BIXLER EO, VGONTZAS AN, LIN HM et al.: Prevalence of sleep-disordered breathing in women: effects of gender. Am. J. Respir. Crit. Care Med. (2001) 163(3 Pt 1):608-613.
   PubMed Web of Science ®Google Scholar
• FERINI-STRAMBI L, FANTINI ML, CASTRONOVO C: Epidemiology of obstructive sleep apnea syndrome. Minerva Med. (2004) 95(3):187-202.
   PubMedGoogle Scholar
• ABAD VC, GUILLEMINAULT C: Central sleep apnea. In: Sleep and its Disorders. Handbook of Clinical Neurophysiology (Volume 60). Guilleminault C (Ed.) Elsevier, Philadelphia, USA (2005):207-221.
   Google Scholar
• CANOVA CR, DOWNS SH, KNOBLAUCH A, ANDERSSON M, TAMM M, LEUPPI JD: Increased prevalence of perennial allergic rhinitis in patients with obstructive sleep apnea. Respiration (2004) 71(2):138-143.
   PubMed Web of Science ®Google Scholar
• KIELY JL, NOLAN P, MCNICHOLAS WT: Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax (2004) 59(1):50-55.
   PubMed Web of Science ®Google Scholar
• BROUILLETTE RT, MANOUKIAN JJ, DUCHARME FM et al.: Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J. Pediatr. (2001) 138(6):838-844.
   PubMed Web of Science ®Google Scholar
• MANSFIELD LE, DIAZ G, POSEY CR, FLORES-NEDER J: Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann. Allergy Asthma Immunol. (2004) 92(2):240-244.
   PubMed Web of Science ®Google Scholar
• BRAVER HM, BLOCK AJ: Effect of nasal spray, positional therapy, and the combination thereof in the asymptomatic snorer. Sleep (1994) 17(6):516-521.
   PubMed Web of Science ®Google Scholar
• GOTHE B, STROHL KP, LEVIN S, CHERNIACK NS: Nicotine: a different approach to treatment of obstructive sleep apnea. Chest (1985) 87(1):11-17.
   PubMed Web of Science ®Google Scholar
• DAVILA DG, HURT RD, OFFORD KP, HARRIS CD, SHEPARD JW JR: Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am. J. Respir. Crit. Care Med. (1994) 150(2):469-474.
   PubMed Web of Science ®Google Scholar
• ZEVIN S, SWED E, CAHAN C: Clinical effects of locally delivered nicotine in obstructive sleep apnea syndrome. Am. J. Ther. (2003) 10(3):170-175.
   PubMedGoogle Scholar
• FERBER C, DUCLAUX R, MOURET J: Naltrexone improves blood gas patterns in obstructive sleep apnoea syndrome through its influence on sleep. J. Sleep Res. (1993) 2(3):149-155.
   PubMed Web of Science ®Google Scholar
• GUILLEMINAULT C, HAYES B: Naloxone, theophylline, bromocriptine, and obstructive sleep apnea. Negative results. Bull. Eur. Physiopathol. Respir. (1983) 19:632-634.
   PubMedGoogle Scholar
• ATKINSON RL, SURATT PM, WILHOIT SC, RECANT L: Naloxone improves sleep apnea in obese humans. Int. J. Obes. (1985) 9(4):233-239.
   PubMed Web of Science ®Google Scholar
• GREENBERG HE, RAPOPORT DM, ROTHENBERG SA, KANENGISER LA, NORMAN RG, GOLDRING RM: Endogenous opiates modulate the postapnea ventilatory response in the obstructive sleep apnea syndrome. Am. Rev. Respir. Dis. (1991) 143(6):1282-1287.
   PubMedGoogle Scholar
• HU K, LI Q, YANG J, HU S, CHEN X: The effect of theophylline on sleep-disordered breathing in patients with stable chronic congestive heart failure. Chin. Med. J. (2003) 116(11):1711-1716.
   PubMed Web of Science ®Google Scholar
• JAVAHERI S, PARKER TJ, WEXLER L, LIMING JD, LINDOWER P, ROSELLE GA: Effect of theophylline on sleep-disordered breathing in heart failure. N. Engl. J. Med. (1996) 335(8):562-567.
   PubMed Web of Science ®Google Scholar
• ESPINOZA H, ANTIC R, THORNTON AT, MCEVOY RD: The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea syndrome. Am. Rev. Respir. Dis. (1987) 136(1):80-84.
   PubMed Web of Science ®Google Scholar
• SALETU B, OBERNDORFER S, ANDERER P et al.: Efficiency of continuous positive airway pressure versus theophylline therapy in sleep apnea: comparative sleep laboratory studies on objective and subjective sleep and awakening quality. Neuropsychobiology (1999) 39(3):151-159.
   PubMed Web of Science ®Google Scholar
• MULLOY E, MCNICHOLAS WT: Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest (1992) 101:753-757.
   PubMed Web of Science ®Google Scholar
• CHARDON K, BACH V, TELLIEZ F et al.: Effect of caffeine on peripheral chemoreceptor activity in premature neonates: interaction with sleep stages. J. Appl. Physiol. (2004) 96(6):2161-2166.
   Google Scholar
• DE CAROLIS MP, ROMAGNOLI C, MUZII U et al.: Pharmacokinetic aspects of caffeine in premature infants. Dev. Pharmacol. Ther. (1991) 16(3):117-122.
   PubMedGoogle Scholar
• CURZI-DASCALOVA L, AUJARD Y, GAULTIER C, RAIGURU M: Sleep organization is unaffected by caffeine in premature infants. J. Pediatr. (2002) 140(6):766-771.
   PubMed Web of Science ®Google Scholar
• BAIRAM A, BOUTROY MJ, BADONNEL Y, VERT P: [The choice between theophylline and caffeine in the treatment of apnea in premature infants] Arch. Fr. Pediatr. (1990) 47(6):461-465.
   PubMedGoogle Scholar
• SURATT PM, WILHOIT SC, BROWN ED, FINDLEY LJ: Effect of doxapram on obstructive sleep apnea. Bull. Eur. Physiopathol. Respir. (1986) 22(2):127-131.
   PubMedGoogle Scholar
• YOUNG T, FINN L, AUSTIN D, PETERSON A: Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am. J. Respir. Crit. Care Med. (2003) 167(9):1181-1185.
   PubMed Web of Science ®Google Scholar
• MANBER R, KUO TF, CATALDO N, COLRAIN IM: The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep (2003) 26(2):163-168.
   PubMed Web of Science ®Google Scholar
• POLO-KANTOLA P, RAUHALA E, HELENIUS H, ERKKOLA R, IRJALA K, POLO O: Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet. Gynecol. (2003) 102(1):68-75.
   PubMed Web of Science ®Google Scholar
• BLOCK AJ, WYNNE JW, BOYSEN PG, LINDSEY S, MARTIN C, CANTOR B: Menopause, medroxyprogesterone and breathing during sleep. Am. J. Med. (1981) 70(3):506-510.
   PubMed Web of Science ®Google Scholar
• COOK WR, BENICH JJ, WOOTEN SA: Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest (1989) 96(2):262-266.
   PubMed Web of Science ®Google Scholar
• STROHL KP, HENSLEY MJ, SAUNDERS NA, SCHARF SM, BROWN R, INGRAM RH JR: Progesterone administration and progressive sleep apneas. JAMA (1981) 245(12):1230-1232.
   PubMed Web of Science ®Google Scholar
• COLLOP NA: Medroxyprogesterone acetate and ethanol-induced exacerbation of obstructive sleep apnea. Chest (1994) 106(3):792-799.
   PubMed Web of Science ®Google Scholar
• RAJAGOPAL KR, ABBRECHT PH, JABBARI B: Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest (1986) 90(6):815-821.
   PubMed Web of Science ®Google Scholar
• CISTULLI PA, BARNES DJ, GRUNSTEIN RR, SULLIVAN CE: Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax (1994) 49(7):699-702.
   PubMed Web of Science ®Google Scholar
• SCHNEIDER BK, PICKETT CK, ZWILLICH CW et al.: Influence of testosterone on breathing during sleep. J. Appl. Physiol. (1986) 61(2):618-623.
   PubMed Web of Science ®Google Scholar
• LIU PY, YEE B, WISHART SM et al.: The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J. Clin. Endocrinol. Metab. (2003) 88(8):3605-3613.
   PubMed Web of Science ®Google Scholar
• STEWART DA, GRUNSTEIN RR, BERTHON-JONES M, HANDELSMAN DJ, SULLIVAN CE: Androgen blockade does not affect sleep-disordered breathing or chemosensitivity in men with obstructive sleep apnea. Am. Rev. Respir. Dis. (1992) 146(6):1389-1393.
   PubMed Web of Science ®Google Scholar
• LIN CC, TSAN KW, CHEN PJ: The relationship between sleep apnea syndrome and hypothyroidism. Chest (1992) 102(6):1663-1667.
   PubMed Web of Science ®Google Scholar
• RESTA O, PANNACCIULLI N, DI GIOIA G, STEFANO A, BARBARO MP, DE PERGOLA G: High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr. Metab. Cardiovasc. Dis. (2004) 14(5):248-253.
   PubMed Web of Science ®Google Scholar
• HUDGEL DW, THANAKITCHARU S: Pharmacologic treatment of sleep-disordered breathing. Am. J. Respir. Crit. Care Med. (1998) 158(3):691-699.
   Google Scholar
• MAGALANG UJ, MADOR MJ: Behavioral and pharmacologic therapy of obstructive sleep apnea. Clin. Chest Med. (2003) 24(2):343-353.
   PubMed Web of Science ®Google Scholar
• RAJAGOPAL KR, ABBRECHT PH, DERDERIAN SS et al.: Obstructive sleep apnea in hypothyroidism. Ann. Intern. Med. (1984) 101(4):491-494.
   PubMed Web of Science ®Google Scholar
• HIRA HS, SIBAL L: Sleep apnea syndrome among patients with hypothyroidism. J. Assoc. Physicians India (1999) 47(6):615-618.
   PubMedGoogle Scholar
• GRUNSTEIN RR, SULLIVAN CE: Sleep apnea and hypothyroidism: mechanisms and management. Am. J. Med. (1988) 85(6):775-779.
   PubMed Web of Science ®Google Scholar
• BLANCO PEREZ JJ, BLANCO-RAMOS MA, ZAMARRON SANZ C, SOUTO FERNANDEZ A, MATO MATO A, LAMELA LOPEZ J: Acromegaly and sleep apnea. Arch. Bronconeumol. (2004) 40(8):355-359.
   PubMed Web of Science ®Google Scholar
• HERRMANN BL, WESSENDORF TE, AJAJ W, KAHLKE S, TESCHLER H, MANN K: Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with Acromegaly. Eur. J. Endocrinol. (2004) 151(3):309-315.
   PubMed Web of Science ®Google Scholar
• ZIEMER DC, DUNLAP DB: Relief of sleep apnea in acromegaly by bromocriptine. Am. J. Med. Sci (1988) 295(1):49-51.
   PubMed Web of Science ®Google Scholar
• PLANES C, FOUCHER A, LEROY M, DARTOIS N, JUSTE K, BAILLART O, RAFFESTIN B: Effect of celiprolol treatment in hypertensive patients with sleep apnea. Sleep (1999) 22(4):507-513.
   PubMed Web of Science ®Google Scholar
• MAYER J, WEICHLER U, HERRES-MAYER B, SCHNEIDER H, MARX U, PETER JH: Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity. J. Cardiovasc. Pharmacol. (1990) 16(6):952-961.
   PubMed Web of Science ®Google Scholar
• GROTE L, WUTKEWICZ K, KNAACK L, PLOCH T, HEDNER J, PETER JH: Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity. Am. J. Hypertens. (2000) 13(12):1280-1287.
   PubMed Web of Science ®Google Scholar
• ISSA FG: Effect of clonidine in obstructive sleep apnea. Am. Rev. Respir. Dis. (1992) 145(2 Pt 1):435-439.
   PubMed Web of Science ®Google Scholar
• HEDNER J, GRUNSTEIN R, ERIKSSON B, EJNELL H: A double-blind, randomized trial of sabeluzole – a putative glutamate antagonist – in obstructive sleep apnea. Sleep (1996) 19(4):287-289.
   PubMed Web of Science ®Google Scholar
• FINNIMORE AJ, ROEBUCK M, SAJKOV D, MCEVOY RD: The effects of the GABA agonist, baclofen, on sleep and breathing. Eur. Respir. J. (1995) 8(2):230-234.
   PubMed Web of Science ®Google Scholar
• TORVALDSSON S, GROTE L, PEKER Y, BASUN H, HEDNER J: A randomized placebo-controlled trial of an NMDA receptor antagonist in sleep-disordered breathing. J. Sleep Res. (2005) 14(2):149-155.
   PubMed Web of Science ®Google Scholar
• WHITE DP, ZWILLICH CW, PICKETT CK, DOUGLAS NJ, FINDLEY LJ, WEILl JV: Central sleep apnea. Improvement with acetazolamide therapy. Arch. Intern. Med. (1982) 142(10):1816-1819.
   PubMed Web of Science ®Google Scholar
• DEBACKER WA, VERBRAECKEN J, WILLEMEN M, WITTESAELE W, DECOCK W, VAN DEHEYNING P. Central apnea index decreases after prolonged treatment with acetazolamide. Am. J. Respir. Crit. Care Med. (1995) 151(1):87-91.
   PubMed Web of Science ®Google Scholar
• HACKETT PH, ROACH RC, HARRISON GL, SCHOENE RB, MILLS WJ JR: Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. Am. Rev. Respir. Dis. (1987) 135(4):896-898.
   PubMedGoogle Scholar
• SHARP JT, DRUZ WS, D'SOUZA V, DIAMOND E: Effect of metabolic acidosis upon sleep apnea. Chest (1985) 87(5):619-624.
   PubMed Web of Science ®Google Scholar
• TOJIMA H, KUNITOMO F, KIMURA H, TATSUMI K, KURIYAMA T, HONDA Y: Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax (1988) 43(2):113-119.
   PubMed Web of Science ®Google Scholar
• WHYTE KF, GOULD GA, AIRLIE MA, SHAPIRO CM, DOUGLAS NJ: Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep (1988) 11(5):463-472.
   PubMed Web of Science ®Google Scholar
• REMMERS JE, DEGROOT WJ, SAUERLAND EK, ANCH AM: Pathogenesis of upper airway occlusion during sleep. J. Appl. Physiol. (1978) 44(6):931-938.
   PubMed Web of Science ®Google Scholar
• BERRY RB, YAMAURA EM, GILL K, REIST C: Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea. Sleep (1999) 22(8):1087-1092.
   PubMed Web of Science ®Google Scholar
• KRAICZI H, HEDNER J, DAHLOF P, EJNELL H, CARLSON J: Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep (1999) 22(1):61-67.
   PubMed Web of Science ®Google Scholar
• HANZEL DA, PROIA NG, HUDGEL DW: Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest (1991) 100(2):416-421.
   PubMed Web of Science ®Google Scholar
• BROWNELL LG, WEST P, SWEATMAN P, ACRES JC, KRYGER MH: Protriptyline in obstructive sleep apnea: a double-blind trial. N. Engl. J. Med. (1982) 307(17):1037-1042.
   PubMed Web of Science ®Google Scholar
• SMITH PL, HAPONIK EF, ALLEN RP, BLEECKER ER: The effects of protriptyline in sleep-disordered breathing. Am. Rev. Respir. Dis. (1983) 127(1):8-13.
   PubMed Web of Science ®Google Scholar
• HEDNER J, KRAICZI H, PEKER Y, MURPHY P: Reduction of sleep-disordered breathing after physostigmine. Am. J. Respir. Crit. Care Med. (2003) 168(10):1246-1251.
   PubMed Web of Science ®Google Scholar
• GUILLEMINAULT C, PHILIP P: Tiredness and somnolence despite initial treatment of obstructive sleep apnea syndrome (what to do when an OSAS patient stays hypersomnolent despite treatment). Sleep (1996) 19(9 Suppl):S117-S122.
   Google Scholar
• ARNULF I, HOMEYER P, GARMA L, WHITELAW WA, DERENNE JP: Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. Respiration (1997) 64(2):159-161.
   PubMed Web of Science ®Google Scholar
• HEITMANN J, CASSEL W, GROTE L, BICKEL U, HARTLAUB U, PENZEL T, PETER JH: Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea? Clin. Pharmacol. Ther. (1999) 65(3):328-335.
   PubMed Web of Science ®Google Scholar
• PACK AI, BLACK JE, SCHWARTZ JR, MATHESON JK: Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am. J. Respir. Crit. Care Med. (2001) 164(9):1675-1681.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ JR, HIRSHKOWITZ M, ERMAN MK, SCHMIDT-NOWARA W: Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest (2003) 124(6):2192-2199.
   PubMed Web of Science ®Google Scholar
• BLACK JE, HIRSHKOWITZ M: Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep (2005) 28(4):464-471.
   PubMed Web of Science ®Google Scholar
• KINGSHOTT RN, VENNELLE M, COLEMAN EL, ENGLEMAN HM, MACKAY TW, DOUGLAS NJ: Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am. J. Respir. Crit. Care Med. (2001) 163(4):918-923.
   PubMed Web of Science ®Google Scholar
• VGONTZAS AN, ZOUMAKIS E, LIN HM, BIXLER EO, TRAKADA G, CHROUSOS GP: Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J. Clin. Endocrinol. Metab. (2004) 89(9):4409-4413.
   PubMed Web of Science ®Google Scholar
• HUDGEL DW, HENDRICKS C, DADLEY A: Alteration in obstructive apnea pattern induced by changes in oxygen- and carbon-dioxide-inspired concentrations. Am. Rev. Respir. Dis. (1988) 138(1):16-29.
   PubMedGoogle Scholar
• SZOLLOSI I, JONES M, MORRELL MJ, HELFET K, COATS AJ, SIMONDS AK: Effect of CO2 inhalation on central sleep apnea and arousals from sleep. Respiration (2004) 71(5):493-498.
   PubMed Web of Science ®Google Scholar
• BADR MS, GROSSMAN JE, WEBER SA: Treatment of refractory sleep apnea with supplemental carbon dioxide. Am. J. Respir. Crit. Care Med. (1994) 150(2):561-564.
   PubMed Web of Science ®Google Scholar
• VILLIGER PM, HESS CW, REINHART WH: Beneficial effect of inhaled CO2 in a patient with non-obstructive sleep apnoea. J. Neurol. (1993) 241(1):45-48.
   PubMed Web of Science ®Google Scholar
• FARNEY RJ, WALKER JM, ELMER JC, VISCOMI VA, ORD RJ: Transtracheal oxygen, nasal CPAP and nasal oxygen in five patients with obstructive sleep apnea. Chest (1992) 101(5):1228-1235.
   PubMed Web of Science ®Google Scholar
• CHAUNCEY JB, ALDRICH MS: Preliminary findings in the treatment of obstructive sleep apnea with transtracheal oxygen. Sleep (1990) 13(2):167-174.
   PubMed Web of Science ®Google Scholar
• SMITH PL, HAPONIK EF, BLEECKER ER: The effects of oxygen in patients with sleep apnea. Am. Rev. Respir. Dis. (1984) 130(6):958-963.
   PubMedGoogle Scholar
• GOLD AR, BLEECKER ER, SMITH P: A shift from central and mixed sleep apnea to obstructive sleep apnea resulting from low-flow oxygen. Am. Rev. Respir. Dis. (1985) 132(2):220-223.
   PubMedGoogle Scholar
• LANDSBERG R, FRIEDMAN M, ASCHER-LANDSBERG J: Treatment of hypoxemia in obstructive sleep apnea. Am. J. Rhinol. (2001) 15(5):311-313.
   PubMedGoogle Scholar
• KUSHIDA CA, LITTNER MR, MORGENTHALER T et al: Practice parameters for the indications for polysomnography and related procedures: An update for 2005. Sleep (2005) 28(4):499-521.
   PubMed Web of Science ®Google Scholar